Thus, this study concluded that docetaxel treated with SH003 synergistically induced apoptotic cell death by inhibiting the EGFR–STAT3 signaling pathway in EGFR wild-type NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.